Deafness, Autosomal Recessive 12
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Prelingual sensorineural hearing impairment
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the eye
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Familial benign hypercalcemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
It has been suggested that the parathyroid glands and the kidneys are insensitive to the high extracellular calcium levels found in familial benign hypercalcaemia (FBH) (familial hypocalciuric hypercalcaemia) and that there may be a general disorder of the plasma membrane 'calcium pump'.
|
3160102 |
1985 |
Congenital Heart Defects
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The PMCA2 gene is contained within this region and deletion of this gene may cause congenital heart defects.
|
7951234 |
1994 |
Von Hippel-Lindau Syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We have isolated and ordered yeast artificial chromosomes (YACs) and cosmids surrounding the von Hippel-Lindau (VHL) tumor suppressor and plasma membrane Ca(2+)-transporting ATPase isoform 2 (PMCA-2) genes on chromosome 3p25-26.
|
8162598 |
1994 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
We have isolated and ordered yeast artificial chromosomes (YACs) and cosmids surrounding the von Hippel-Lindau (VHL) tumor suppressor and plasma membrane Ca(2+)-transporting ATPase isoform 2 (PMCA-2) genes on chromosome 3p25-26.
|
8162598 |
1994 |
Von Hippel-Lindau Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
These results have (i) established the position of the VHL disease gene with respect to D3S601, (ii) refined the localisation of the VHL disease gene to a small region (approximately 50 kb) of chromosome 3p25-p26 and (iii) excluded the plasma membrane Ca(+)+-transporting ATPase isoform 2 (PMCA-2) gene as a candidate gene for VHL disease.
|
8364570 |
1993 |
Essential Hypertension
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Investigation of the Met-267 Arg exchange in isoform 1 of the human plasma membrane calcium pump in patients with essential hypertension by the amplification-created restriction site technique.
|
9020386 |
1997 |
Essential Hypertension
|
0.020 |
Biomarker
|
disease |
BEFREE |
Combined SSCP and heteroduplex analysis of the human plasma membrane Ca(2+)-ATPase isoform 1 in patients with essential hypertension.
|
10425217 |
1999 |
Hypertensive disease
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Moreover, expression of PMCA (1b and 4b), SERCA3a, and rSERCA3b/3c was modulated in rat hypertension.
|
10642281 |
2000 |
Malignant neoplasm of breast
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
Our results also indicate that breast cancer cell lines can express mRNAs for a variety PMCA isoforms.
|
12359307 |
2002 |
Breast Carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Our results also indicate that breast cancer cell lines can express mRNAs for a variety PMCA isoforms.
|
12359307 |
2002 |
Carcinogenesis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
To determine if PMCA expression is altered in tumorigenesis, we compared relative levels of PMCA1 mRNA.
|
12359307 |
2002 |
Encephalomyelitis
|
0.020 |
AlteredExpression
|
disease |
LHGDN |
Temporal pattern of plasma membrane calcium ATPase 2 expression in the spinal cord correlates with the course of clinical symptoms in two rodent models of autoimmune encephalomyelitis.
|
15926914 |
2005 |
Mammary Neoplasms
|
0.020 |
AlteredExpression
|
group |
LHGDN |
Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines.
|
16216224 |
2005 |
Sensorineural Hearing Loss (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although other genes in this region remain candidates, we conclude that haploinsufficiency of ATP2B2 is the most likely cause of SNHL in 3p-- syndrome.
|
17208398 |
2007 |
Distal monosomy 3p syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although other genes in this region remain candidates, we conclude that haploinsufficiency of ATP2B2 is the most likely cause of SNHL in 3p-- syndrome.
|
17208398 |
2007 |
Deafness, Autosomal Recessive 12
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafness.
|
17234811 |
2007 |
Malignant neoplasm of breast
|
0.070 |
Biomarker
|
disease |
BEFREE |
Recent studies associate alterations in calcium transporter expression with tumourigenesis, such as changes in specific isoforms of the plasma membrane calcium ATPase (PMCA) in breast cancer cell lines.
|
17321497 |
2007 |
Breast Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Recent studies associate alterations in calcium transporter expression with tumourigenesis, such as changes in specific isoforms of the plasma membrane calcium ATPase (PMCA) in breast cancer cell lines.
|
17321497 |
2007 |
hearing impairment
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
We can also conclude that deletion of the gene ATP2B2 alone is not enough to cause hearing impairment, which is frequently found in patients with 3p deletion.
|
17696125 |
2007 |
Cataract
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Elevated PMCA2 expression in cataractous lenses might be a compensatory mechanism to overcome higher intracellular calcium levels in cataract.
|
18223301 |
2008 |
Wolfram Syndrome 1
|
0.010 |
Biomarker
|
disease |
BEFREE |
DNA analysis to examine single-nucleotide polymorphisms in 2 candidate modifier genes (ATP2B2 and Wolfram syndrome 1 [WFS1]) is summarized in this report.
|
18667942 |
2008 |
blood phenylalanine measurement by Guthrie microbiologic assay
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum.
|
19043545 |
2008 |